van Dijk Fleur S, Angwin Chloe, Ghali Neeti, Zschocke Johannes, Wagner Bart
London North West University Health Care NHS Trust National EDS service, London North West University Health Care, NHS Trust Watford Road HA1 3UJ Harrow United Kingdom.
London North West University Health Care NHS Trust National EDS service Watford Road HA1 3UJ Harrow United Kingdom.
Med Genet. 2024 Dec 3;36(4):247-254. doi: 10.1515/medgen-2024-2062. eCollection 2024 Dec.
With increased application of Next Generation Sequencing (NGS) in the diagnosis of monogenic Ehlers-Danlos syndromes, there is an increased probability to identify variants of unknown significance. Additionally, in some cases no genetic alteration may be identified whilst there is a strong clinical suspicion on a monogenic EDS type. The diagnostic value of non-genetic investigations, which prior to NGS were quite commonly used to support the clinical diagnosis of monogenic EDS types, is explored. In addition, new structural/functional investigations that could deliver evidence towards pathogenicity are discussed. It appears that certain functional and/or structural investigations used frequently in the past can remain helpful and can provide additional evidence that may confirm a clinical diagnosis of a monogenic EDS type. However, there is a need for the development of novel structural/functional studies for monogenic types of EDS. The level of evidence of such studies for application in the established diagnostic DNA variant classification criteria remains to be determined.
随着下一代测序(NGS)在单基因埃勒斯-当洛综合征诊断中的应用增加,识别意义未明变异的可能性也在增加。此外,在某些情况下,尽管临床高度怀疑为单基因EDS类型,但可能未发现基因改变。本文探讨了在NGS之前常用于支持单基因EDS类型临床诊断的非基因检查的诊断价值。此外,还讨论了能够提供致病性证据的新的结构/功能检查。过去经常使用的某些功能和/或结构检查似乎仍然有用,并可提供额外证据以证实单基因EDS类型的临床诊断。然而,对于单基因EDS类型,需要开展新的结构/功能研究。此类研究应用于既定诊断DNA变异分类标准的证据水平仍有待确定。